, and the 36-month beta value for MNKD is at 1.59. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The average price suggested by analysts for MNKD is $6.70, which is $2.35 above the current market price. The public float for MNKD is 261.43M, and currently, shorts hold a 14.97% of that float. The average trading volume for MNKD on September 18, 2023 was 2.81M shares.
MNKD) stock’s latest price update
MannKind Corporation (NASDAQ: MNKD)’s stock price has plunge by -0.91relation to previous closing price of 4.39. Nevertheless, the company has seen a 1.40% surge in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-09-05 that WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it will be participating at upcoming conferences.
MNKD’s Market Performance
MannKind Corporation (MNKD) has seen a 1.40% rise in stock performance for the week, with a -13.86% decline in the past month and a 3.82% surge in the past quarter. The volatility ratio for the week is 2.97%, and the volatility levels for the past 30 days are at 3.58% for MNKD. The simple moving average for the past 20 days is -5.41% for MNKD’s stock, with a -4.65% simple moving average for the past 200 days.
Analysts’ Opinion of MNKD
Many brokerage firms have already submitted their reports for MNKD stocks, with RBC Capital Mkts repeating the rating for MNKD by listing it as a “Sector Perform.” The predicted price for MNKD in the upcoming period, according to RBC Capital Mkts is $5 based on the research report published on May 14, 2021 of the previous year 2021.
MNKD Trading at -5.22% from the 50-Day Moving Average
After a stumble in the market that brought MNKD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.35% of loss for the given period.
Volatility was left at 3.58%, however, over the last 30 days, the volatility rate increased by 2.97%, as shares sank -12.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.97% upper at present.
During the last 5 trading sessions, MNKD rose by +1.40%, which changed the moving average for the period of 200-days by -1.36% in comparison to the 20-day moving average, which settled at $4.57. In addition, MannKind Corporation saw -17.46% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MNKD starting from Castagna Michael, who sale 10,000 shares at the price of $4.61 back on Sep 01. After this action, Castagna Michael now owns 2,436,039 shares of MannKind Corporation, valued at $46,100 using the latest closing price.
Thomson David, the EVP Genl Counsel & Secretary of MannKind Corporation, sale 8,100 shares at $4.78 during a trade that took place back on Aug 28, which means that Thomson David is holding 798,835 shares at $38,738 based on the most recent closing price.
Stock Fundamentals for MNKD
Current profitability levels for the company are sitting at:
- -69.08 for the present operating margin
- +42.37 for the gross margin
The net margin for MannKind Corporation stands at -87.60. The total capital return value is set at -43.46, while invested capital returns managed to touch -58.54. Equity return is now at value 18.90, with -15.80 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 8.76, with the company’s debt to enterprise value settled at 0.25. The receivables turnover for the company is 9.16 and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.49.
In conclusion, MannKind Corporation (MNKD) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.